Dr Patel on the Efficacy of Anitocabtagene Autoleucel in R/R Multiple Myeloma | OncLive
Dr Patel on the Efficacy of Anitocabtagene Autoleucel in R/R …
1 month ago
onclive.com
Autolus Therapeutics plc: Autolus Therapeutics Announces First Patient Dosed in Phase 1 Trial of Obecabtagene Autoleucel (Obe-Cel) in Patients with Progressive Multiple Sclerosis
Autolus Therapeutics plc: Autolus Therapeutics Announces First Pat…
2 months ago
finanznachrichten.de
Dr. Till on the Utility of Brexucabtagene Autoleucel in MCL
Dr. Till on the Utility of Brexucabtagene Autoleucel in MCL
Apr 6, 2021
onclive.com
Autolus Therapeutics plc: Autolus Therapeutics' CAR T Therapy AUCATZYL (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor ...
Autolus Therapeutics plc: Autolus Therapeutics' CAR T Therapy AUC…
5 months ago
finanznachrichten.de
Dr. Deol on the Approval of Brexucabtagene Autoleucel in MCL | OncLive
Dr. Deol on the Approval of Brexucabtagene Autoleucel in MC…
Sep 17, 2020
onclive.com
Dr. Epperla on the Efficacy of Brexucabtagene Autoleucel in MCL | OncLive
Dr. Epperla on the Efficacy of Brexucabtagene Autoleucel in MC…
Jun 16, 2021
onclive.com
Dr. Jacobson on FDA Approval of Brexucabtagene Autoleucel in Relapsed/Refractory MCL
Dr. Jacobson on FDA Approval of Brexucabtagene Autoleucel in Rel…
Oct 26, 2020
onclive.com
Dr. Shah on Results Seen With Brexucabtagene Autoleucel in Rel…
Jun 11, 2021
onclive.com
Is There a Potential Role for Rapcabtagene Autoleucel in R/R L…
Feb 7, 2023
onclive.com
14:59
Influences on Treatment Response and Survival in Recipients of Brex…
Feb 9, 2024
onclive.com
Dr. Goy on the Durability of Response With Brexucabtagene A…
May 6, 2021
onclive.com
Dr Shah on Zamtocabtagene Autoleucel’s Favorable Safety Pro…
9 months ago
onclive.com
Outcomes Data Following Brexucabtagene Autoleucel Thera…
Sep 6, 2023
onclive.com
Dr Bishop on 34-Month Data With Anitocabtagene Autoleucel in R/R …
Dec 23, 2024
onclive.com
Dr Riedell on Efficacy and Safety of Rapcabtagene Autoleucel in R/R D…
Jan 3, 2025
onclive.com
Dr Ikegawa on An Analysis of Rapidly Manufactured Durcabtage…
Oct 5, 2023
onclive.com
Outcomes Following Brexucabtagene Autoleucel Admi…
Jun 27, 2023
onclive.com
Phase 2 Registrational Study of Anitocabtagene Autoleucel for th…
2 weeks ago
onclive.com
Adaptimmune Therapeutics plc: Adaptimmune Receives U.S. FDA …
Feb 8, 2024
finanznachrichten.de
2:25
A MAIC of linvoseltamab versus ide-cel and cilta-cel in triple-class-exp…
41 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:51
Novartis Immunology: Advancing Bold Science for Autoimmune Dis…
2 views2 months ago
YouTubeCosmic Room
NICE Approves AUCATZYL: New CAR T Therapy for Relapsed B-Cel…
2 views1 month ago
YouTubeTrí Tuệ Sáng Suốt
2:20
Association between CAR-T expansion and delayed neurotoxic…
89 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
8:34
Zamtocabtagene autoleucel significantly improves event-free s…
4 weeks ago
Vimeoecancer
3:28
CARVYKTI Breakthrough: 2.5 Year Remissions in Early Multiple Myel…
1 month ago
YouTubeShared Horizons
4:02
Anitocabtagene autoleucel achieves deep and durable responses in rel…
4 weeks ago
Vimeoecancer
1:53
Ciara Freeman, MD, PhD: Phase 2 QUINTESSENTIAL study of arlo-ce…
7 views1 month ago
YouTubeMoffitt Cancer Center
4:05
NICE Recommends AUCATZYL for Adult R/R B-ALL Treatment in the …
1 month ago
YouTubeThe Open Spectrum
3:55
What Is The Recovery Process After Brexucabtagene Autoleucel? - On…
1 views4 months ago
YouTubeOncology Support Network
1:05
Rapcabtagene autoleucel for patients with first-line high-risk LB…
21 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder